PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.73%
Revenue growth above 1.5x ADI's 7.67%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.88%
Gross profit growth above 1.5x ADI's 5.66%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
23.57%
EBIT growth similar to ADI's 23.33%. Walter Schloss might infer both firms share similar operational efficiencies.
23.57%
Operating income growth similar to ADI's 23.33%. Walter Schloss would assume both share comparable operational structures.
38.27%
Net income growth 1.25-1.5x ADI's 25.93%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
60.00%
EPS growth above 1.5x ADI's 33.33%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
60.00%
Diluted EPS growth above 1.5x ADI's 33.33%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-10.96%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-10.96%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
22.52%
Dividend growth of 22.52% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
121.15%
OCF growth at 50-75% of ADI's 224.69%. Martin Whitman would question if the firm lags in monetizing sales effectively.
219.05%
FCF growth similar to ADI's 239.73%. Walter Schloss would attribute it to parallel capital spending and operational models.
57.39%
10Y revenue/share CAGR at 50-75% of ADI's 96.58%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
30.73%
5Y revenue/share CAGR at 50-75% of ADI's 57.19%. Martin Whitman would worry about a lagging mid-term growth trajectory.
32.70%
3Y revenue/share CAGR 1.25-1.5x ADI's 28.97%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
78.94%
3Y OCF/share CAGR above 1.5x ADI's 2.27%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
747.03%
10Y net income/share CAGR of 747.03% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
18.05%
Net income/share CAGR of 18.05% while ADI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
921.88%
3Y net income/share CAGR above 1.5x ADI's 100.00%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.89%
Negative 3Y equity/share growth while ADI is at 1.88%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
77.23%
Dividend/share CAGR of 77.23% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
64.10%
Dividend/share CAGR of 64.10% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
0.36%
3Y dividend/share CAGR of 0.36% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
3.67%
AR growth well above ADI's 6.49%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.00%
Inventory growth well above ADI's 1.89%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.34%
Asset growth well under 50% of ADI's 7.79%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
18.75%
BV/share growth above 1.5x ADI's 9.66%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.71%
We’re deleveraging while ADI stands at 24.97%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
11.28%
SG&A growth well above ADI's 2.32%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.